4//SEC Filing
Froimson Mark 4
Accession 0001209191-18-038190
CIK 0001396814other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:13 PM ET
Size
7.4 KB
Accession
0001209191-18-038190
Insider Transaction Report
Form 4
Froimson Mark
Director
Transactions
- Award
Common Stock
2018-06-13+782→ 882 total - Award
Stock Option (Right to Buy)
2018-06-13+4,693→ 4,693 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (4,693 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001709050
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 7:13 PM ET
- Size
- 7.4 KB